Matthew L. Posard
Director · HALOZYME THERAPEUTICS, INC.
IndividualSelling only8 10b5-1 trades
- 2025
- Oct 2, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Matthew L. Posard files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
- Cortney Caudill - $1.96M in HALO purchases and sales in the last 12 months
- Bernadette Connaughton - $699K in HALO purchases and sales in the last 12 months
- Mahesh Krishnan - $548K in HALO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matthew L. Posard?
Matthew L. Posard is a corporate insider, tracked as Director of HALOZYME THERAPEUTICS, INC. (HALO). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Matthew L. Posard submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Matthew L. Posard been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($2.61M) across all tracked filings.
